-
Appointee holds a PhD or equivalent doctorate (e.g. ScD, MD, DVM). Candidates with non-US degrees may be required to provide proof of degree equivalency. 1. A candidate may also be appointed to a postdoctoral
-
-throughput in vitro screening; 2) mechanistic studies, and 3) in vivo validation PhD in pharmacology, toxicology, biochemistry, cell biology, chemical biology, or a closely related field Hands-on experience
-
effectively with other members of the research team. Requirements: Earned a doctorate (PhD, MD/MPH, etc.) in implementation science Demonstrated proficiency through previous research experience implementation
-
, Physics, Applied Mathematics, Computer Science, or a related area. Experience 0+ years of postgraduate experience. Skills The candidate must have excellent skills in conducting independent research and
-
international programs in more than 150 countries. The Pratt School of Engineering at Duke University is one of the fastest rising, highly ranked engineering schools in the nation. The school consists of four
-
communities in the gut, blood and other bodysites; immune profiling; biomarker assays; metabolomics; clinical outcomes research; and systems-based biology and computational multi-omics approaches
-
Qualifications at this Level Education/Training: PhD (theoretical nuclear/high-energy physics, quantum information science, lattice gauge theories, quantum many-body dynamics) Experience: Preferred--computational
-
Appointee holds a PhD or equivalent doctorate (e.g. ScD, MD, DVM). Candidates with non-US degrees may be required to provide proof of degree equivalency. 1. A candidate may also be appointed to a postdoctoral
-
software. Receive tailored mentorship in grant writing (e.g., NIH K99/R00), career planning, and leadership. Minimum Qualifications: The candidate should hold a PhD (or equivalent) in Computer Science
-
foundation for an independent research trajectory. REGAL is a multidisciplinary research program integrating social epidemiology, molecular epidemiology, and global health to investigate the drivers of cancer